Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21
Yosr Hamdi(Tunis University), Anna Jakubowska(Pomeranian Medical University), Véronique Adoue(Université Toulouse III - Paul Sabatier), Volker Arndt(German Cancer Research Center), Angela Cox, Mark S. Goldberg(Friends United), Hiltrud Brauch(German Cancer Research Center), Sander Canisius(University of Cambridge), Natalia Bogdanova(Medizinische Hochschule Hannover), Fergus J. Couch(Mayo Clinic), Peter A. Fasching(Universitätsklinikum Erlangen), Graham G. Giles(The University of Melbourne), Jenny Chang‐Claude(Universität Hamburg), Simon S. Cross(University of Sheffield), John L. Hopper(The University of Melbourne), Thilo Dörk(Hannover Re (Germany)), Jonine D. Figueroa, Annegien Broeks, Joe Dennis(University of Cambridge), Caroline Baynes(University of Cambridge), Pascal Guénel(Inserm), Mikael Eriksson(Herlev Hospital), Anna González‐Neira(Spanish National Cancer Research Centre), Kamila Czene(Karolinska Institutet), Kyriaki Michailidou(Cyprus Institute of Neurology and Genetics), Peter Devilee(Leiden University), Irene L. Andrulis(University of Toronto), Henrik Flyger(Gentofte Hospital), Carl Blomqvist(University of Helsinki), Ute Hamann(German Cancer Research Center), Arnaud Droit(Université Laval), Stig E. Bojesen(University of Copenhagen), Montserrat García‐Closas(Institute of Cancer Research), Hermann Brenner(Universidad de Granada), Hoda Anton‐Culver(University of California, Irvine), Bernardo Bonanni(European Institute of Oncology), Judith S. Brand(Institute of Cancer Research), Audrey Lemaçon(University of Cambridge), Barbara Burwinkel(German Cancer Research Center), Emily Hallberg(University of Kansas Medical Center), Hatef Darabi, Anne‐Lise Børresen‐Dale(Oslo University Hospital), Christopher A. Haiman(University of Southern California), Maartje J. Hooning(University of Copenhagen), Penny Soucy(University of Cambridge), Manjeet K. Bolla(University of Cambridge), Grethe Irene Grenaker-Alnæs(Oslo University Hospital), Lothar Haeberle(Friedrich-Alexander-Universität Erlangen-Nürnberg), Isabel dos‐Santos‐Silva(London School of Hygiene & Tropical Medicine)
Cited by 42
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k